Skip to main content
Onco-Innovations logo

Onco-Innovations — Investor Relations & Filings

Ticker · ONCO ISIN · CA68237C1059 NEO Professional, scientific and technical activities
Open in API
Filings indexed 86 across all filing types
Latest filing 2025-03-25 Capital/Financing Update
Country CA Canada
Listing NEO ONCO

About Onco-Innovations

https://oncoinnovations.com/

Onco-Innovations is a biotechnology company specializing in oncology research and the development of cutting-edge therapies to prevent and treat cancer. The company focuses on next-generation treatments, particularly those targeting solid tumors, leveraging an exclusive global license for patented technology. To advance precision oncology, Onco-Innovations utilizes the SynoGraph™ AI platform (acquired through Inka Health) to accelerate patient identification, optimize treatment planning, and streamline its drug development pipeline.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release providing an update on the use of proceeds from the company’s equity financing (prospectus) including a detailed table of funds raised and spent, reallocation of funds, and commentary on financing activities. This falls squarely within the Capital/Financing Update category rather than an earnings release or annual/interim report. Hence, it is classified as a Capital/Financing Update (CAP).
2025-03-25 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a regulatory certification (Form 52-109FV2) under Canadian NI 52-109 for interim filings, signed by the CEO, rather than the interim report itself or an announcement of its publication. It does not present financial results or MD&A content, nor is it a notice of timing. It is a compliance filing falling under miscellaneous regulatory filings.
2025-03-04 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing a research study and forward‐looking statements. It does not present financial results (so it’s not an Earnings Release or an Interim/Quarterly/Annual Report), nor does it relate to corporate governance, board changes, dividends, M&A, or other specific filings. It is a general company announcement that does not fit any other specialized category, so it defaults to the Regulatory Filings fallback category (RNS).
2025-02-28 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release (press release) announcing preclinical study results for a novel nanoparticle cancer therapy, containing forward-looking statements and a CEO quote. It is not a financial report, management discussion, earnings release, capital raising, AGM material, or any other specific regulatory filing category. As a general corporate announcement that does not fit other categories, it falls under the fallback category of “Regulatory Filings” (RNS).
2025-02-17 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release providing updates on Onco-Innovations’ licensed PNKP inhibitor technology and the engagement of a market-making service provider. It is not an earnings release (no financial results), not a formal regulatory report (10-K, IR, AR, etc.), nor a specific notice like dividends, governance, M&A, or share transactions. It falls under miscellaneous public announcements, making it a general regulatory filing (RNS).
2025-02-11 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate news release announcing an Expression of Interest (EOI) between the company’s subsidiary and another firm for potential collaboration on data analytics. It does not present financial results (ER, IR, 10-K), changes in board or management (MANG), capital financing (CAP), M&A or takeover bids (TAR), share issues or buybacks (SHA/POS), voting matters (DVA), or any other narrowly defined category. It is a general corporate announcement/press release—best classified under the fallback “Regulatory Filings” category (RNS).
2025-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.